Pre-open movers
US stock futures traded lower in early pre-market trade, ahead of earnings from Morgan Stanley MS. Data on weekly jobless claims and housing starts for June will be released at 8:30 a.m. ET. The general conditions index of the Philadelphia Fed's Survey will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average tumbled 71 points to 16,986.00, while the Standard & Poor's 500 index futures fell 12.60 points to 1,962.20. Futures for the Nasdaq 100 index dropped 26 points to 3,896.50.
A Peek Into Global Markets
European markets were lower today, with the Spanish Ibex Index falling 1.21%, STOXX Europe 600 Index dropping 0.90%. German DAX 30 index declined 0.98%, French CAC 40 Index tumbled 1.06% and London's FTSE 100 Index dropped 0.73%.
In Asian markets, Japan's Nikkei Stock Average fell 0.06%, Hong Kong's Hang Seng Index declined 0.01%, China's Shanghai Composite Index dropped 0.57% and India's BSE Sensex gained 0.04%.
Broker Recommendation
Analysts at Janney Capital upgraded Time Warner TWX from Neutral to Buy. The target price for Time Warner has been raised from $71.90 to $100.
Time Warner's shares closed at $83.13 yesterday.
Breaking news
Market News and Data brought to you by Benzinga APIs- Philip Morris International PM reported better-than-expected second-quarter results. To read the full news, click here.
- SAP SE SAP reported a 23% drop in its second-quarter profit and lifted its full-year revenue forecast for cloud applications. To read the full news, click here.
- Salix Pharmaceuticals SLXP and Pharming Group NV PHGUF today announced that the Food and Drug Administration has approved RUCONEST (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg for the treatment of acute angioedema attacks in adult and adolescent patients with hereditary angioedema (HAE). To read the full news, click here.
- Shares of UnitedHealth Group UNH surged around 3.7% in pre-market trading after the company reported upbeat second-quarter earnings and raised its revenue forecast. To read the full news, click here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in